Overdiagnosis in cancer.

By H. Welch, W. Black. Journal of the National Cancer Institute, 2010

1,610 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/54709914327317d25bde17c2fb4a8e31a7b044fa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. A. Jemal
2. F. Bray
3. M. Laversanne
4. J. Lortet-Tieulent
5. M. Colombet
6. Douglas G. Altman
7. A. Billis
8. R. Siegel

In Pulmonary and Respiratory Medicine

1. S. Thompson
2. Douglas G. Altman
3. A. Jemal
4. A. Billis

In Radiology, Nuclear Medicine and Imaging

1. Douglas G. Altman
2. A. Jemal
3. A. Billis

Citations in the corpus

• Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. (2011, background): “These findings emphasize the prevalence of overdiagnosis and overtreatment of prostate cancer.(4) Today, the majority of men diagnosed with prostate cancer are older than age 65 years and have low- to intermediate-risk disease.”
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening (2011, neutral): “Overdiagnosis, a major source of controversy surrounding low-dose CT lung-cancer screening, results from the detection of cancers that never would have become symptomatic.(28) Although additional follow-up would be necessary to measure the magnitude of overdiagnosis in the NLST, a comparison of the ”
• The benefits and harms of breast cancer screening: an independent review (2013, positive): “The panel illustrates how different approaches yield various estimates using data from the Malmö trial (Andersson et al, 1988; Zackrisson et al, 2006), partly following Welch (Welch et al, 2006; Welch and Black, 2010).”
• Overdiagnosis and Overtreatment of Prostate Cancer (2014, methodology): “Welch HG, Black WC. Overdiagnosis in cancer.”
• Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer (2014, neutral): “With 7 y follow-up 21 (16-25) 9 (6-12) 85 (69-93) 71 (52-83) 31 (27-34) 19 (16-23)”
• Thyroid cancer mortality and incidence: A global overview (2015, background): “Thus, the rise in thyroid cancer incidence does not appear to reflect a real increase in the occurrence of this neoplasm, but it is more likely due to a substantial increment in the detection of subclinical thyroid cancers (such as small papillary carcinomas) over the last decades, particularly in y”
• Review of quantitative ultrasound: envelope statistics and backscatter coefficient imaging and contributions to diagnostic ultrasound (2016, background): “As a result, a cancer “overdiagnosis” problem has occurred [2], [3] in which many biopsies are being conducted because of suspicious image findings with the vast majority of these biopsies having negative findings [4].”
• Spectrum of Cancer Risk among U.S. Solid Organ Transplant Recipients: The Transplant Cancer Match Study (2011, neutral): “Additionally, transplant recipients may appear to have elevated risk for some cancers (eg, melanoma, cancers of the kidney or thyroid) because of heightened medical surveillance.(39) Finally, we could not evaluate squamous cell and basal cell skin cancers because these tumors are not collected by ca”
• International incidence of childhood cancer, 2001–10: a population-based registry study (2017, background): “Cancer statistics in high-income countries might be influenced by overdiagnosis of some cancers detected by non-invasive imaging and screening tests, including neuroblastoma, thyroid cancer, melanoma, and kidney cancer.(17)”